Total Payments
$5,280
2024 Payments
$1,104
Companies
32
Transactions
311
Medicare Patients
2,799
Medicare Billing
$237,807
Payment Breakdown by Category
Food & Beverage$5,185 (98.2%)
Other$95.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,185 | 310 | 98.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $708.85 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $687.77 | 51 | $0 (2024) |
| Lilly USA, LLC | $679.42 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $650.97 | 37 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $423.23 | 21 | $0 (2019) |
| GlaxoSmithKline, LLC. | $337.43 | 14 | $0 (2024) |
| Amgen Inc. | $324.05 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $181.57 | 12 | $0 (2019) |
| Galderma Laboratories, L.P. | $142.46 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $120.74 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,104 | 50 | Lilly USA, LLC ($259.75) |
| 2023 | $392.34 | 21 | Novo Nordisk Inc ($117.65) |
| 2020 | $402.56 | 12 | Galderma Laboratories, L.P. ($142.46) |
| 2019 | $1,049 | 64 | Merck Sharp & Dohme Corporation ($243.48) |
| 2018 | $1,033 | 73 | Merck Sharp & Dohme Corporation ($161.27) |
| 2017 | $1,300 | 91 | SANOFI-AVENTIS U.S. LLC ($226.82) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.17 | General |
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes Care | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: VACCINE | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Obesity | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Oncology | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: VACCINES | ||||||
| 06/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Inflammation | ||||||
| 06/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 06/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 721 | 1,057 | $277,550 | $56,599 |
| 2022 | 11 | 658 | 1,010 | $225,630 | $45,039 |
| 2021 | 14 | 677 | 989 | $167,435 | $73,086 |
| 2020 | 13 | 743 | 1,019 | $168,067 | $63,083 |
Total Patients
2,799
Total Services
4,075
Medicare Billing
$237,807
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 515 | $141,625 | $19,916 | 14.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 47 | 47 | $31,020 | $13,272 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 144 | 144 | $40,320 | $5,504 | 13.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 64 | 65 | $8,775 | $4,669 | 53.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 44 | $15,400 | $2,698 | 17.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 77 | $4,235 | $2,468 | 58.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 29 | $16,530 | $2,122 | 12.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,620 | $1,698 | 36.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 47 | $2,585 | $1,506 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 34 | $6,460 | $1,433 | 22.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 27 | $4,860 | $1,169 | 24.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $1,120 | $144.60 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 530 | $125,750 | $20,042 | 15.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 152 | 152 | $37,604 | $6,389 | 17.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $10,560 | $4,466 | 42.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 60 | 63 | $8,260 | $4,295 | 52.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 72 | 75 | $3,936 | $2,332 | 59.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 26 | 32 | $16,315 | $2,182 | 13.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 31 | $9,750 | $1,696 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 39 | $6,310 | $1,627 | 25.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 19 | 24 | $4,280 | $1,077 | 25.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $913.00 | $652.43 | 71.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 24 | 26 | $1,952 | $280.65 | 14.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 192 | 489 | $95,355 | $29,712 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 136 | 136 | $26,656 | $19,515 | 73.2% |
About Dr. Philip Perilstein, MD
Dr. Philip Perilstein, MD is a Family Medicine healthcare provider based in Warmisnter, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841294220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Perilstein, MD has received a total of $5,280 in payments from pharmaceutical and medical device companies, with $1,104 received in 2024. These payments were reported across 311 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,185).
As a Medicare-enrolled provider, Perilstein has provided services to 2,799 Medicare beneficiaries, totaling 4,075 services with total Medicare billing of $237,807. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Warmisnter, PA
- Active Since 06/13/2005
- Last Updated 11/27/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841294220
Products in Payments
- FARXIGA (Drug) $347.01
- JANUVIA (Drug) $328.92
- SOLIQUA (Drug) $246.44
- Ozempic (Drug) $222.45
- JARDIANCE (Drug) $213.57
- TRULICITY (Drug) $187.72
- Prolia (Biological) $184.31
- MOUNJARO (Drug) $159.26
- AIRSUPRA (Drug) $152.32
- GARDASIL (Biological) $143.22
- Victoza (Drug) $125.64
- BEXSERO (Biological) $124.76
- SHINGRIX (Biological) $120.76
- TREMFYA (Drug) $120.74
- TOUJEO (Drug) $119.56
- SYMBICORT (Drug) $119.11
- Wegovy (Drug) $108.67
- Kerendia (Drug) $80.19
- BASAGLAR (Drug) $79.72
- Myrbetriq (Drug) $79.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.